|
Non-EPA group (n = 53)
|
EPA group (n = 54)
|
P value
|
---|
Age (y.o)
|
68.9 ± 8.8
|
67.8 ± 9.1
|
0.49
|
Sex (male, n, %)
|
43 (81.1 %)
|
44 (81.5 %)
|
0.84
|
Coronary risk factor
|
Hypertension (n, %)
|
49 (92.5 %)
|
48 (88.9 %)
|
0.76
|
Dyslipidemia (n, %)
|
53 (100 %)
|
54 (100 %)
|
0.99
|
Smoking (n, %)
|
4 (7.5 %)
|
5 (9.3 %)
|
0.98
|
Concomitant use drug
|
Statin (n, %)
|
44 (83.0 %)
|
46 (85.2 %)
|
0.97
|
Calcium channel blocker (n, %)
|
30 (56.6 %)
|
27 (50.0 %)
|
0.62
|
ACEI/ARB (n, %)
|
35 (66.0 %)
|
40 (74.1 %)
|
0.49
|
- Values are presented as number (%) or mean ± standard deviation, as indicated
-
ACEI angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker